Company Filing History:
Years Active: 1992
Title: Wolfgang Hennig: Innovator in Photodynamic Therapy
Introduction
Wolfgang Hennig is a notable inventor based in Cologne, Germany. He has made significant contributions to the field of photodynamic therapy through his innovative research and development.
Latest Patents
Hennig holds a patent for "Acetylene-cumulene porphycene compounds for photodynamic therapy." This patent includes dihydro- and tetrahydro-acetylene-cumulene porphycene compounds, which are recognized for their utility as photodynamic therapy agents. He has 1 patent to his name.
Career Highlights
Hennig has established himself as a key figure in his field, working with Cytopharm, Inc. His work focuses on advancing therapeutic techniques that leverage the unique properties of porphycene compounds.
Collaborations
Throughout his career, Hennig has collaborated with esteemed colleagues, including Emanuel Vogel and Alexander D. Cross. These partnerships have contributed to the advancement of research in photodynamic therapy.
Conclusion
Wolfgang Hennig's contributions to photodynamic therapy through his innovative patents and collaborations highlight his importance in the field. His work continues to influence advancements in medical treatments.